AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Levofloxacin Hemihydrate in Zambia
8 products registered with ZAMRA — 8 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Levobact 750 tablets Film Coated Tablets | 315/003 | MICRO LABS LTD | active | 1 Jul 2030 |
| Levoflox-Denk Solution for Injection | 130/101 | Denk Pharma GmbH & Co. KG | active | 26 Dec 2029 |
| Levo- Denk 500 tablets Film Coated Tablets | 130/071 | Denk Pharma GmbH & Co. KG | active | 7 Jun 2029 |
| Safelevo 500 tablets Tablet Uncoated | 311/020 | MSN Laboratories Private Limited | active | 7 Jun 2029 |
| Safelevo 750 tablets Tablet Uncoated | 311/009 | MSN Laboratories Private Limited | active | 1 Jun 2029 |
| Uvex- 500 tablets Tablet Uncoated | 019/027 | MEYER ORGANICS PVT. LTD. | active | 25 May 2029 |
| Uvex- 750 tablets Film Coated Tablets | 019/028 | MEYER ORGANICS PVT. LTD. | active | 25 May 2029 |
| Levocin 500 Infusion (Levofloxacin Hemihydrate 500mg) Injection | ZAMRA-HM-23-04 | PT Sanbe Farma | active | 29 Feb 2028 |
Levofloxacin Hemihydrate — ZAMRA Registration Details
ZAMRA (Zambia) has 8 registered products containing Levofloxacin Hemihydrate, of which 8 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Levofloxacin Hemihydrate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.